Article: Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer.

Article: Agendia Launches TargetPrint(R) for Breast ...
PR Newswire Europe;  September 4, 2008 ;     700+ words ... ... significant number of breast cancer patients," said ... executive officer of Agendia. "TargetPrint ... key customers." Agendia will present clinical ... TargetPrint at The 2008 Breast Cancer Symposium which ... under development. Agendia was the first company ... clearance for a ...

Article: Agendia's MammaPrint(R), the Only FDA-Cleared ...
PR Newswire;  December 12, 2007 ;     700+ words ... ... PRNewswire/ -- Agendia makes its breast cancer prognosis test ... IVDMIA) for use in breast cancer prognosis. In June of this year, Agendia received a second ... predicts the risk of breast cancer recurrence. Agendia maintains close ...

Article: Frost & Sullivan Award Recognizes Agendia BV's Pioneering ...
Business Wire;  October 25, 2007 ;     700+ words ... ... field of biomarker-based breast cancer diagnostics is presented to Netherlands-based Agendia BV, for its new method of translating a breast cancer prognosis microarray signature ... MammaPrint([R]). Agendia's product offering employs ...

Article: Agendia Working to Develop First Microarray-Based ...
Business Wire;  August 21, 2003 ;     700+ words ... ... Authors of Landmark Breast Cancer Study Form New ... Application of Their Breast Cancer Research Findings ... NYSE:A) and Agendia B.V. today announced ... aggressiveness of breast cancer tumors based on ... United States. Agendia will handle the ...

Article: Agendia Presents Data Supporting MammaPrint's Predictive ...
PR Newswire Europe;  March 11, 2009 ;     700+ words ... ... researchers from Agendia and the Netherlands ... 2009 St.Gallen Breast Cancer Conference ... prognostic power of Agendia's breast cancer recurrence test ... conducted in Agendia's CLIA-accredited ... laboratory. Breast cancer recurrence assays ...

Article: Agendia BV Announces That its Chief Research Officer Laura ...
PR Newswire Europe;  October 22, 2007 ;     700+ words ... ... meticulous work enabled Agendia to become the first ... s MammaPrint(R) breast cancer test. We are very pleased ... Bernhard Sixt, CEO of Agendia. About Agendia Agendia ... expression profiling. Agendia was the first company ... predicts the risk of breast cancer ...

Article: Agendia BV Announces That its Chief Research Officer Laura ...
PR Newswire;  October 22, 2007 ;     700+ words ... ... meticulous work enabled Agendia to become the first ... its MammaPrint(R) breast cancer test. We are very pleased ... Bernhard Sixt, CEO of Agendia. About Agendia Agendia ... expression profiling. Agendia was the first company ... predicts the risk of breast cancer ...